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PERUMUSAN,  PENCIRIAN  DAN  PENGOPTIMUMAN  ESTER  MINYAK 
SAWIT BERDASARKAN  EMULSI  BERSKALA NANO  UNTUK  
PENGHANTARAN TOPIKAL  IBUPROFEN  SERTA  PENILAIAN KESAN  
ANTI-INFLAMASI DAN ANALGESIK 
 
ABSTRAK 
 
tujuan utama kajian ini adalah untuk formulasi  ibuprofen sebagai suatu 
emulsi berskala nano baru, yang terdiri daripada ester minyak sawit tersintesis baru 
sebagai fasa minyak. 
Kajian ini melibatkan pembinaan beberapa gambarrajah fasa pseudo-ternari 
terdiri daripada air, ester minyak sawit, dan campuran surfaktan bukan ion bagi beberapa 
nilai HLB. Beberapa formula  atau rumusan dipilih bagi mengukur  kelarutan  ibuprofen.  
Di samping itu, kesan ibuprofen terhadap pelbagai sifat formula yang dipilih turut 
dinilai. Sifat reologi,  potensi  zeta, saiz titisan dan ciri struktur formula juga dikaji.   
Satu formula dengan komposisi asas ester minyak sawit:  fasa akues: surfaktan 
(100% Tween 80, HLB 15) pada nisbah  25:37:38 dipilih untuk pengubahsuaian 
selanjutnya dari segi sifat pengawetan aliran dan  penelapan.  Beberapa emulsi berskala 
nano dalam pelbagai kepekatan ibuprofen dan penampan fosfat pada tiga nilai pH yang 
berbeza ; 4.0, 6.0 dan 7.4 dihasilkan dan kesan bagi setiap parameter di atas turut dinilai. 
 xxii 
 
Asid benzoik, natrium benzoat serta metil dan propil paraben diuji sebagai pengawet. 
Tiga resin Carbopol
®
 iaitu 934, 940 dan Ultrez 10 digunakan sebagai penyesuai  reologi. 
Sifat pembengkakan dan pembentukan rangkaian-gel Carbopol 940 dinilai dengan 
menggunakan agen peneutralan yang berbeza (penampan fosfat dan larutan  
trietanolamina) pada beberapa nilai pH dan kepekatan. Mentol and limonen pada 
kepekatan berbeza digunakan sebagai penggalak penelapan (permeation promoters) 
ibuprofen melalui kulit.  
Kemampuan beberapa emulsi berskala nano menghantar ibuprofen melalui kulit 
tikus dinilai secara in vitro dengan menggunakan sel resapan Franz. Formulasi-formulasi 
CS,7.4T,0R, CS,7.4T,0.50R940,M10 dan CS,7.4T,0.50R940,M10 ditemui sebagai yang terbaik dan 
kesan farmakodinamiknya dinilai dan dibandingkan dengan sediaan komersial. Aktiviti 
anti-inflamasi dan analgesik daripada formula tersebut diukur  melalui kaedah  
“carragennan-induced hind paw edema  
Sebagai kesimpulan, emulsi berskala nano terdiri daripada 5% w/w ibuprofen 
sebagai bahan kandungan aktif, ester minyak sawit sebagai fasa minyak, 0.5% w/w 
Carbopol
®
 940 sebagai penyesuai reologi yang dineutralkan oleh larutan akues 
trietanolamina pH 7.4 sebagai fasa luaran, dan 10% w/w mentol atau  limonene sebagai 
penggalak penelapan didapati mempunyai sifat  reologi, saiz titisan dan kestabilan yang 
sesuai. 
 Formula CS,7.4T,0.50R940,M10 dan CS,7.4T,0.50R940,M10 menunjukkan sifat 
penelapan in vitro yang sangat baik melalui kulit tikus dibandingkan dengan produk 
sedia ada dalam pasaran (Nurofen
®
 5% Gel).  Sehubungan dengan kesan anti-inflamasi 
 xxiii 
 
dan   analgesik yang amat tinggi apabila dibandingkan dengan produk rujukan, maka 
kedua-dua formula ini dipilih sebagai produk akhir. Kedua-duanya juga didapati stabil 
pada suhu yang berbeza sepanjang tempoh pemerhatian. 
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FORMULATION, CHARACTERIZATION AND OPTIMIZATION OF PALM 
OIL ESTERS BASED NANO-SCALED EMULSIONS FOR TOPICAL 
DELIVERY OF IBUPROFEN AND THE EVALUATION OF THEIR ANTI-
INFLAMMATORY AND ANALGESIC EFFECTS  
 
ABSTRACT 
 
The main aim of this study stands on formulating ibuprofen as a novel nano-
scaled emulsion encompassing newly synthesized palm oil esters as the oil phase. 
This study involved the construction of several pseudo-ternary phase diagrams of 
water, palm oil esters and non-ionic surfactant mixture of several Hydrophilic-Lipophilic 
Balance (HLB) values. Several promising formulae were chosen, where ibuprofen 
solubility was measured. Additionally, the effect of ibuprofen on various properties of 
the selected formulations were also evaluated. Rheological properties, zeta potential, 
droplets size and structural characteristics of the promising formulae were also studied.  
A formula with a basic composition of palm oil esters: aqueous phase: surfactant 
(100% Tween 80, HLB 15) at a ratio 25:37:38 respectively was selected for further 
modification in terms of preservation and flow and permeation properties. Several nano-
scaled emulsions containing various ibuprofen concentrations and phosphate buffer at 
three different pH values; 4.0, 6.0 and 7.4 were produced and assessed for their effects 
 xxv 
 
on the above parameters.  Benzoic acid, sodium benzoate and methyl and propyl 
parabens were tested as preservatives. Three Carbopol
®
 resins, namely 934, 940 and 
Ultrez 10 were later used as rheology modifiers. Carbopol 940 gel-network forming and 
swelling properties were evaluated using different neutralizing agents (phosphate buffer 
and triethanolamine solutions) at several pH values and concentrations. Menthol and 
limonene at two different concentrations were utilized as permeation promoters of 
ibuprofen through the skin.  
The ability of several selected nano-scaled emulsions to deliver ibuprofen 
through full thickness rat skin was assessed in vitro using Franz diffusion cell. 
Formulations CS,7.4T,0R, CS,7.4T,0.50R940,M10 and CS,7.4T,0.50R940,M10 were found to be 
the most promising formulae and their pharmacodynamic effects were evaluated and 
compared with a reference preparation available commercially. The anti-inflammatory 
and analgesic activities of these formulae were measured by using carragennan-induced 
hind paw edema method. 
In conclusion, the nano-scaled emulsions comprising 5% w/w ibuprofen as the 
active ingredient, palm oil esters as the oil phase, 0.5% w/w Carbopol
®
 940 as the 
rheology modifier neutralized by triethanolamine aqueous solution pH 7.4 as the 
external phase, and 10% w/w menthol or limonene as the permeation enhancer were 
found to have suitable rheological, droplets size and stability properties. 
 Formulae CS,7.4T,0.50R940,M10 and CS,7.4T,0.50R940,M10 showed better in vitro permeation 
properties through full thickness rat skin compared to the marketed product (Nurofen
®
 
5% Gel). As a consequence of their higher anti-inflammatory and analgesic effects 
 xxvi 
 
compared to that of the reference product, these two formulations were selected as the 
final products. These formulae were also found stable at different temperatures over the 
observation period. 
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CHAPTER ONE 
INTRODUCTION 
 
1.1. Introduction 
During the last few decades, the treatment of many sicknesses has been achieved 
by administrating various drugs to humans via different routes which are namely: oral, 
sublingual, rectal, parental, inhalation, topical delivery, etc. Topical drug delivery has 
been considered by many researchers to be of extensive importance (Klotz and Schwab, 
2005, Lopes et al., 2005, Huang et al., 2008, Zhu et al., 2009). It can be defined as the 
application of a formulation containing a drug to the skin to directly treat cutaneous 
disorders (e.g. acne) or to the cutaneous manifestations of a general disease (e.g. 
psoriasis) with the intention of producing pharmacological or other effects of drugs on 
the surface of the skin, within the skin or to tissues under the skin. 
The topical application of medicines was launched in the ancient history and the 
nineteen forties witnessed the topical administration of antibiotics and hormones. 
Generally, any agent whether toxic or beneficial to the human body, is susceptible to be 
absorbed if it comes into contact with the skin. Topical delivery systems may include 
drug administration to the skin for various purposes, such as steroid for local effect to 
treat dermatitis, nicotine patches for systemic effects, cosmetics for surface effect and 
NSAIDs for effects on deeper tissues like inflamed muscle. 
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1.2. Advantages and Disadvantages of Topical Drug Delivery Systems 
Generally, topical delivery systems are considered versatile pharmaceutical 
dosage forms and have several applications in pharmacy. These systems include dosage 
forms, such as gels, ointments, creams, etc. They possess many advantages over 
conventional dosage forms; nonetheless, they also have several negative drawbacks that 
limit their usage in some circumstances (Walters and Roberts, 2002a).  
 
1.2.1. Advantages of Topical Drug Delivery Systems 
At the first place, topical dosage forms usually avoid liver first pass effect, which 
is considered as the potential barrier or limiting factor for most orally administered 
medications. Secondly, topically applied systems are convenient to be used by patients 
due to the ease of their application. As they function topically, they normally bypass the 
risks and hassles of intravenous injections (Park et al., 2000). Moreover, topical drug 
delivery can skip the variation in absorptive conditions of the gastrointestinal tract 
(GIT), including; diversity of pH values from mouth to colon, enzymes activity, gastric 
emptying time and so forth. They can even avoid the fluctuation in drug plasma levels of 
inter- and intra-subject variations. Finally, topical dosage forms are self-applicable to a 
relatively large body area that can be simply terminated when required. 
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1.2.2. Disadvantages of Topical Drug Delivery Systems 
Apart from all the benefits of topical dosage forms, they also own some 
disadvantages. First, skin irritations or allergies are quite common problems that are 
usually caused by drugs and/or excipients leading sometimes to skin dermatitis. 
Secondly, skin permeation of some drugs is occasionally poor due to the complexity of 
skin structure in general and stratum corneum, the outermost layer in specific (Huang et 
al., 2005, Russeau et al., 2009). Drugs absorption can be worsen if the dosage form 
consists of large droplets. In addition, enzymes available mainly in the epidermis of the 
skin can denature the applied preparation. Lastly, these dosage forms are more effective 
locally, i.e. their applications are more to be local than systemic. They can be utilized to 
produce systemic effect only when very small plasma concentrations of drugs are 
required to show a pharmacological action. 
 
1.3. Factors Affecting the Absorption of Drugs through Skin 
Basically, the rate and extent of drug absorption through the skin are influenced 
by the physicochemical properties of the drug and dosage form, skin structure and 
location and skin physiological conditions that most probably affect drug transportation 
to the systemic circulation (Wiechers, 1989).  
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1.3.1. Physicochemical Properties of Drug Substances 
Many physical and chemical properties are influencing drug absorption through 
the skin (Park et al., 2000). These characteristics are:  
Partition coefficient: preferably, a one to four partition coefficient in octanol-
water system is essential for producing a successful topical drug delivery Naik et al. 
(2000). 
Drug solubility: higher drugs permeation through the skin is greatly related to 
their solubilities in the vehicle used in the formulation. Increasing drug solubility causes 
its permeation to be raised. 
Concentration: supersaturated formulations can positively influence drugs 
permeability. In other word, increasing drugs concentrations beyond the saturated levels 
leads to an increase in the thermodynamic activity of these drugs in the vehicle. Higher 
thermodynamic activity is the driving force that can take out greater amounts of drugs 
from the formulation to across the stratum corneum. However, this technique is mainly 
limited by the re-crystallization problem that commonly occurs in supersaturated 
products (Williams, 2003). 
 Particle size: decreasing particles or droplets size of topically applied 
preparation causes the effective absorption area to be increased. As a result, the 
permeation of drugs through the skin becomes higher; therefore, nano- and micro-
emulsion systems are of prime interest. 
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Polymorphism: as mentioned earlier that the permeability of any drug through 
the skin is highly related to its solubility in the vehicle. Therefore, the most soluble 
polymorph of any drug should be chosen in producing the final dosage form.  
Molecular weight: it was reported by Naik et al. (2000) that drugs with a 
molecular weight less than 400 dalton can easily pass through skin tissues. 
 
1.3.2. Release Properties of Topical Drug Delivery Systems  
Emulsion, as a dosage form can accommodate more than one drug because it has 
external and internal phases. When drug molecules are included only in the internal 
phase of an emulsion, then drug molecules need to be partitioned from the internal phase 
to the external phase first before being absorbed by the skin. This process represents the 
rate limiting step of many topical preparations and it should occur quickly if fast 
absorption and effect are needed. Moreover, the release of drug from a dosage form may 
be affected by the composition of drug delivery system. Various excipients used may 
enhance or retard the absorption of drugs, e.g. the low molecular weight of propylene 
glycol may reduce the permeation and absorption of drugs, while polyethylene glycols 
may affect the penetration process oppositely. 
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1.3.3. Physiological and Pathological Conditions of Skin 
Effect of horny reservoir layer: topically applied drugs may bind to the horny 
layer of the skin that in turn acts as a depot for drugs in therapy.  
Lipid film: skin has specific moisture content that is normally controlled by the 
naturally formed lipid films which act as a protective layer to prevent excessive moisture 
loss. 
Skin hydration: the application of an occlusive cover over the skin leads to an 
increase in the degree of hydration of the stratum corneum by preventing moisture loss 
from the skin, which consequently enhances the absorption of drugs.  
Skin temperature: increasing the temperature of the skin may produce a chain 
of events, these are: a raise in drugs thermal energy that augments their diffusion, an 
increase in drugs solubilities in skin tissues and vasodilatation of the blood vessels. 
Overall, all these measures may cause the rate of drug permeation through the skin to 
increase.  
Regional variation: the thickness and nature of skin are also variable properties. 
Various parts of the body demonstrate different thickness and environment. This may 
also affect drugs penetration, which can be anatomically ordered from least to most 
permeating as: plantar anterior, fore arm, scalp, ventral thigh, and scrotum and posterior 
auricular area. 
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Pathologic injuries of the skin: injured skin generally shows an increase in 
drugs permeation. The injury majorly affects the first layer of the skin, stratum corneum, 
which is the main barrier for the penetration of any exterior substance to the body.  
Cutaneous drug metabolism: viable epidermis comprises several metabolizing 
enzymes which may interact with drugs and change them to active or inactive 
metabolites before reaching the circulation. Both topical bioavailability and 
pharmacodynamic activity of drugs may change, for example; testosterone is 95% 
metabolized in the viable epidermis layer (Hadgraft, 2001). 
 
1.4. Penetration Enhancement 
Various approaches have been anticipated by many researchers to enhance the 
passage of drug molecules through the skin by overcoming the normal barriers functions 
which impede most of the foreign molecules including drugs from penetrating through 
the skin (Thomas and Finnin, 2004). Many substances are available to enhance 
chemically drugs permeation through the skin, which can further be increased by 
physical methods.  
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1.4.1. Chemical Penetration Enhancers 
A reversible damage or alteration in the nature of the stratum corneum is the 
mechanism of action of most chemical penetration enhancers. Such substances can 
achieve these changes via increasing the hydration of the stratum corneum and/or 
changing the lipid and lipoprotein structure.  These enhancers include: 
Solvents: liquids like water, alcohol, ethanol, propylene glycol, glycerol 
isopropyl palmitate, etc may enhance the penetration process by swelling the polar 
pathway of the stratum corneum and/or liquefying the lipids of this membrane.  
Surfactants: these compounds are supposed to improve permeation by 
reversibly disturbing the stratum corneum (Shokri et al., 2001). The commonly used 
surfactants are: 
i. Anionic surfactants: these surfactants are potent permeation enhancers, 
though they can irritate or interact strongly with the skin. Examples include dioctyl 
sulpho succinate, sodium lauryl sulphate, etc.  
ii. Cationic surfactants: these surfactants are reported to be more irritating 
to the skin than the anionic surfactants, thus they are very rarely used for enhancing skin 
permeation. 
iii. Non-ionic surfactants: these are the surfactants with the least potential to 
cause skin irritation. Examples are Tweens and Spans, which are widely used in topical 
dosage forms (Black, 1993). 
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1.4.2. Physical Methods for Enhancing Topical Drug Delivery 
Iontophoresis: it is a technique that utilizes an electric current of appropriate 
polarity to deliver ionic or charged molecules into a skin tissue by the passage of an 
electrolyte solution containing these ionic molecules (Prausnitz et al., 1996). 
Electro-poration: this is a method that relies on causing rapid dissociation of the 
stratum corneum via the application of transiently high voltage electrical pulse of 250 
volts. The rapid dissociation involves structural and conductance changes in the cell 
membranes causing skin pore size and subsequently absorption to increase (Prausnitz et 
al., 1996). 
Sonophoresis: low frequency ultrasound waves of (25 kHz) are used in this 
method to improve penetration.  
Phonophoresis: in this technique, an ultrasound-coupling agent is placed over 
the area on the skin to be treated. This area is then massaged with an ultrasound source. 
The movement of drugs through skin under the ultrasound perturbation is known as 
phonophoresis.  
Vesicular Concept: the technology of various vesicles, like liposomes, niosomes 
and transferosomes can be employed to enhance drugs penetration as they can reversibly 
alter the permeability of the cell membranes. 
Microfabricated Microneedles Technology: in this technique, silicon micro-
needles are prepared to load in various drugs.  The introduction of micro-needles into the 
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skin creates conduits for the transfer of the drug through the stratum corneum. This is 
usually followed by further diffusion of drug into the systemic circulation (Prausnitz, 
2004, Teo et al., 2006). 
 
1.5. Semisolid Topical Drug Delivery Systems 
Topical medications involved mainly two semi-solid dosage forms that are 
creams and ointments. Ointment is a water-free topical delivery system utilizing 
lipophilic vehicles, such as liquid paraffin to dissolve drugs. Conversely, cream is an 
aqueous system comprising water, oil and surfactant or emulsifier. The emulsifier is 
used to keep the oil dispersed consistently in the water or vice versa. Therefore, creams 
can be classified as oil in water (o/w) dispersed systems, where oil represents the 
internal phase and water is the external phase and inversely water in oil (w/o) dispersed 
systems. In other words, creams are said to be o/w or w/o emulsions that have a colloidal 
gel structure (Junginger, 1994). Emulsions, micro-emulsions and nano-emulsions 
possess many advantages that render them efficient carriers for many drugs required to 
be topically delivered (Williams, 2007b). 
 
1.5.1. Emulsions 
Emulsion is a mixture of at least two immiscible liquids, one of which is 
dispersed as globules, to constitute the dispersed or internal phase, in the other liquid 
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(the continuous or external phase) that tend to contain these globules. Without the 
addition of the emulsifying agent as the third component such system turns immediately 
into two separated phases via various destabilizing processes, like creaming (or 
sedimentation), flocculation, coalescence or phase inversion (Masmoudi et al., 2005). In 
other words, the emulsifying agent is crucial for the continuation of a uniform dispersion 
of these immiscible liquids. Emulsifying agent usually locates itself at the interface 
formed between these two phases to reduce the interfacial tension normally arises upon 
mixing the immiscible liquids. The dispersed phase droplets’ size ranges between 0.1 to 
10 mm. Even though emulsions show several problems with regard to their stability, 
they have been used extensively to improve the solubility, absorption and bioavailability 
of poorly water-soluble drugs (Eccleston, 2007). 
 
1.5.2. Micro-Emulsions 
Micro-emulsion is a thermodynamically stable system formed spontaneously 
without an extensive mechanical input during the mixing process. It possesses very 
small droplets size that usually lies in the range of 20-200 nm (Kwon and Bourne, 1997, 
Esposito et al., 2003, Cai et al., 2007, Hickey et al., 2010), which renders micro-
emulsion to be translucent or transparent in appearance (Lawrence and Rees, 2000). The 
micro-emulsion free energy is expressed as (γ A) where γ is the interfacial tension that 
formed upon mixing the two immiscible liquids and A is the overall new interfacial area 
produced following the formation of the emulsion. A is largely high due to the extreme 
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small droplets size, but γ is nearly zero, as the function of  surfactants is to efficiently 
reduce the interfacial tension, which makes the free energy of the system almost zero.  
Such excessive reduction in the interfacial tension is usually achieved by either 
using two auxiliary surfactants or surfactant-co-surfactant system (Moulik and Paul, 
1998). The usage of adjuvant surfactants or surfactant and co-surfactant can create a 
synergistic effect in reducing the interfacial tension through the formation of a mixed 
layer at the interface. Consequently, the interfacial tension is further decreased so as to 
be of negative value. Such combined surfactant systems are used, since single surfactant 
is mostly insufficient to reduce the interfacial tension to the extent that the system can be 
formed spontaneously. Some non-ionic surfactants and double alkyl chain surfactant 
were found to be capable in producing micro-emulsion systems (Biruss and Valenta, 
2008). 
Micro-emulsion systems have wide pharmaceutical domains due to their superior 
properties over conventional emulsions. These systems are mainly characterized by three 
structures; the o/w, the w/o and the bi-continuous micro-emulsions. The first two types 
represent systems where oil micro-droplets are dispersed in the water external phase and 
vice versa, respectively. While the bi-continuous system is the one in which both water 
and oil phases are present as a continuous phase separated by a surfactants rich 
interfacial layer (Moulik and Paul, 1998). Bi-continuous micro-emulsions are usually 
associated with systems containing equivalent amounts of oil and water.  
Surfactant plays an essential role in determining the type of micro-emulsion 
formed. Viscous micro-emulsion, such as viscous micro-emulsion with a gel structure 
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can be produced through the usage of non-ionic surfactant mixtures.  It was found that 
many structures can be formed in micro-emulsion systems. Some of these systems 
mainly showed a combination of hexagonal and cubic crystalline liquid structures 
(Carlfors et al., 1991, Bolzinger et al., 1998). Non-ionic surfactants are well known to 
form highly viscous gel o/w micro-emulsions through H-bond formation between the 
polyoxyethylene chain of the surfactants surrounding the oil droplets (Podlogar et al., 
2004). Lecithin also was found to form a highly viscous w/o micro-emulsion system. It 
has the capability to produce a worm like micelles in which the projected chains from 
each micelle can attach the chain of other micelles to form a network (Paolino et al., 
2002). 
 
1.5.3. Nano-scaled Emulsions 
Nano-scaled emulsion is another emulsion system that resembles micro-
emulsions and differs from conventional emulsions in having very small size droplets 
where their diameter lies in the range of 20-500 nm (Sznitowska et al., 2002, Pey et al., 
2006). It consists of two immiscible liquids in which one liquid is dispersed as fine 
droplets in the other one. Nano-scaled emulsions differ from micro-emulsions as they 
are thermodynamically unstable (Gutiérrez et al., 2008); although they show high kinetic 
stability due to the very small dispersed droplets that reduce effectively their 
sedimentation or creaming (Solans et al., 2005). Despite this kinetic stability, nano-
scaled emulsions can be destabilized by flocculation and Ostwald ripening phenomena. 
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The energy preserved inside the system is the major cause of product degradation 
(Akabori et al., 1978, Welin-Berger and Bergensthl, 2000). 
Production of nano-scaled emulsions may require high energy input; particularly, 
when the concentration of surfactant is low. Two energy methods are reported in the 
literatures, namely: the high energy and low energy methods. The first method involves 
the input of high energy to get the system emulsified and to produce droplets in the 
nano-meter range. Sonication and/or high pressure homogenization can be utilized as an 
efficient source of energy sufficient to transform and break up the internal phase of the 
system into droplets of submicron size (Kentish et al., 2008, Yuan et al., 2008). On the 
other hand, the low energy method comprises phase inversion and temperature inversion 
techniques. Phase inversion is achieved by the gradual addition of the external phase to 
inverse the system into a nano-sized dispersion (Maestro et al., 2008). While, in 
temperature inversion technique, the temperature is firstly raised and then reduced to 
change the hydrophilic nature of the surfactant that results in a nano-scaled dispersed 
system (Solans et al., 2005).  
O/w nano-scaled emulsions have been extensively studied  and  widely used for 
parenteral and topical applications (Benita and Levy, 1993b). Topically, they are 
appropriate in delivering lipophilic drugs as the inner oil phase of nano-scaled emulsions 
can solubilize and accommodate these lipophilic drugs (Sonneville-Aubrun et al., 2004). 
In contrast, w/o nano-scaled emulsion has only been mentioned in publication recently 
(Gutiérrez et al., 2008).  
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Micro-emulsions and nano-emulsions offer many advantages to be used in 
delivering drugs topically. They have a high drug-solubilization power and their various 
constituents provide synergistic effect to enhance drug delivery. Oil, water and 
surfactants mixture or surfactant-co-surfactant mixture can combine synergistically to 
enhance the drug flux (Kreilgaard, 2001). Additionally, the small droplets size is the 
driving force which had contributed to the high interest and active investigation of these 
topical drug delivery systems.  
 
1.5.3.1. Oils Used as Enhancers of Nano-scaled Emulsion Topical Delivery Systems 
 Some oil substances, such as oleic acid (fatty acid) and isopropyl myristate 
(isopropyl ester) frequently used to produce micro- and nano-scaled emulsions have 
been studied extensively as they have been shown to have drug-permeation enhancing 
properties. Chemically, oleic group is an unsaturated alkyl chain comprising 18 carbon 
atoms and demonstrating a cis-configuration. Oleic acid was found to increase the flux 
of 5-fluorouracil through human skin by 56 times (Goodman and Barry, 1989). 
Additionally, this oil improved significantly the topical absorption of amino acid and 
naloxane (Aungst et al., 1986). Likewise, isopropyl myristate has been mentioned as a 
considerable permeation enhancer for topical delivery of steroids (Peltola et al., 2003, 
Djordjevic et al., 2004).  
 Ester wax, a naturally occurring wax found in jojoba oil, is widely used as an oil 
phase in the preparation of various creams and ointments. Physically, this oil is highly 
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stable and has the capability to produce emulsion of reduced droplets size (Chung et al., 
2001). Its ability to enhance the permeability of drugs through the skin is derived from 
its protective and occlusive effects on the skin, which consecutively improves skin 
hydration that leads to a higher penetration rate (Lautenschläger, 2003).  
 
1.5.3.2. Aqueous Phase in Nano-scaled Emulsion Topical Delivery Systems  
Several researchers have reported the usage of water and phosphate buffer pH 
7.4 as the aqueous phase in producing micro-emulsions for topical applications 
(Alvarez-Figueroa and Blanco-Méndez, 2001, Trotta et al., 2003). In all aqueous 
solutions, water is involved as the major component, which can loosen the tightly 
bounded  lipid lamellae of stratum corneum as its absorption leads to the hydration of 
this layer (Walters and Roberts, 1993a). 
 
1.5.3.3. Surfactants Used in Nano-scaled Emulsion Topical Delivery Systems 
Basically, the lipid bilayer of stratum corneum renders it a strong barrier to 
various exterior substances; therefore, materials that can disturb the lipid bilayer are 
capable of making stratum corneum a less effective barrier. Ionic and non-ionic 
surfactants were found to show such effects. Irreversible disturbance of these lipid 
bilayers is extremely discouraged as it could lead to serious skin complications. Ionic 
surfactants were found to promote irreversible changes; therefore, they are not preferred 
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to be used topically. On the contrary, non-ionic surfactants are safe. They enhance drugs 
flux effectively and widely used in topical drug delivery systems. However, dissimilar 
skin species and drug models respond differently to non-ionic surfactant enhancing 
effect (Black, 1993, Endo et al., 1996, Williams, 2003). Table 1.1 illustrates some of the 
researches that were carried out on micro-emulsions using different drugs, oil phases, 
surfactant systems, aqueous phases and membrane models. 
 
Table 1.1:  
Overview of micro-emulsion formulations reported by various researchers 
 
Drug 
Micro-emulsion Skin 
Source Oil phase Surfactant/ co-surfactant Water 
[3H] H2O Octanol dioctyl sodium sulphosuccinate Water Human 
5-Fluorouracil 
Isopropyl 
myristate 
Octadecyltrimethylammoni-um 
bromide 
Water Mouse 
8-Methoxsalen 
Isopropyl 
myristate 
Tween 80
®
, Span 80
®
, 1,2-
octanediol 
Water Pig 
Apomorphine 
hydrochloride 
Isopropyl 
myristate, 
decanol 
Epikuron 200
®
, 1, 2-
propanediol benzyl alcohol 
Water, 
Aerosil 
200® 
Mouse 
Ascorbic acid 
Isopropyl 
palmitate,      
cetearyl 
octanoate 
Dodecylglucoside cocoamide 
propylbetaine, 
phosphatidylcholine/2-ethyl-
1,3-hexanediol 
Water - 
Ascorbyl 
palmitate 
Mygliol 
812® 
Labrasol
®
/Plurol Oleique
®
 Water - 
Diclofenac 
Isopropyl 
palmitate 
Lecithin Water Human 
Diphen-
hydramine 
hydrochloride 
Isopropyl 
myristate 
Tween 80
®
, Span 20
®
 Water Human 
Felodipine 
Isopropyl 
myristate, 
benzyl 
alcohol 
Tween 20
®
, 
Taurodeoxycholate 
Water, 
Transcut-
ol, 
carbopol 
Mouse 
CHAPTER ONE                                                                                                                   
18 
 
Table 1.1. Continue 
 
Glucose Octanol 
Dioctyl sodium, 
sulphosuccinate 
Water Human 
Hemato-
porphyrin 
Isopropyl 
myristate, 
decanol, 
hexadecanol, 
oleic acid, 
monoolein 
Lecithin, 
monohexylphosphate, benzyl 
alcohol 
Water Mouse 
Indomethacin 
Isopropyl 
palmitate 
Lecithin Water Human 
Ketoprofen 
 
Oliec acid, 
Triacetin, 
MYvacet 
Labrasol, Cremophor, RH Water Rat 
Lidocaine 
Isostearylic 
isostearate 
Labrasol, Plurol, Isostearique Water Rat 
Methotrexate Decano 
Lecithin, benzyl alcohol, 
Labrasol / Plurol 
Water, 
PG 
Mouse 
Methotrexate Ethyl oleate Isostearique 
Aq. 145 
mM NaCl 
(pH 7.4) 
Pig 
Methotrexate 
Isopropyl 
myristate 
Tween 80, Span 80, 1,2-
octanediol 
Water Pig 
Nifedipine 
Benzyl 
alcohol 
Tween 20, taurodeoxycholate 
Water, 
Transcuto
l, PG 
Mouse 
Prilocaine  
hydrochloride 
Isostearate Labrasol, Plurol, Isostearique Water Rat 
Propanolol 
Isopropyl 
myristate 
Polysorbate 80 Water Artificial 
Prostaglandin E Oleic acid Labrasol, Plurol, Oleique Water Mouse 
Prostaglandin E Gelucire Labrafac, Lauroglycol 
Transcuto
l, Water 
Mouse 
Sodium 
salicylate 
Isopropyl 
myristate 
Tweens 21
®
, 81 and 85/ bis- 2-
(ethylhexyl) sulphosuccinate 
Water, 
gelatin 
Pig 
Sucrose Ethyl oleate Labrasol, Plurol,  Isostearique 
Aq. 154 
mM NaCl 
Mouse 
*This table is adapted from  (Kreilgaard, 2002). 
 
 
